A positive top-line readout from a phase 3 trial has emboldened Incyte to seek the FDA’s blessing for the company’s Monjuvi as a first-line treatment for diffuse large B-cell lymphoma (DLBCL). The ...

The Metropolitan Detention Center, known as the M.D.C., is one of the United States’ most notorious federal lockups. By Ali Watkins Nicolás Maduro, the Venezuelan president captured by the United ...

Hope Biosciences has linked its stem cell therapy candidate to improved motor function in Parkinson’s disease patients in a phase 2 trial. The single-site study randomized 60 people with early to ...

Nanoflowers, which look white, can help healthy cells, colored yellow, deliver mitochondria, colored red, to nearby cells. Akhilesh K. Gaharwar Most of your cells rely on microscopic structures within ...

The ongoing phase I/II clinical trial is evaluating the safety, tolerability and early efficacy signals of Aleta’s first-in-class biologic CAR T-cell engager, ALETA-001 Preliminary findings include a ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Runergy’s latest TOPCon cell efficiency record was verified by the Institute for Solar Energy Research Hamelin (ISFH) in Germany. Image: Runergy. Chinese solar manufacturer Runergy has reported that ...

Graham Kates is an investigative reporter covering criminal justice, privacy issues and information security for CBS News Digital. Contact Graham at KatesG@cbsnews.com or grahamkates@protonmail.com ...

Trial results could underpin request for regulatory approval Bayer already working on manufacturing network Several other research teams working on similar treatments SAN SEBASTIAN, Spain, Sept 22 ...